Skip to content
  1. Home
  2. Latest news
  3. Johnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.
A brick wall at Johnson & Johnson's headquarters

Johnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.

The vaccine is one of three COVID-19 vaccines sharing joint recognition on the list of groundbreaking innovations this year.

Yesterday, the editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time‘s Best Inventions of 2021.

The vaccine, for which Johnson & Johnson received Emergency Use Authorization from the U.S. Food and Drug Administration in February, is being recognized in the Medical Care category alongside two other COVID-19 vaccines.

Since Johnson & Johnson’s founding 135 years ago, it has been committed to using its reach and size for good. In fact, earlier this year, Johnson & Johnson was chosen for inclusion on the first-ever list of TIME100 Most Influential Companies.

Each year, Time highlights groundbreaking inventions across a range of categories—including technology, beauty, healthcare, food, home and entertainment—that are making the world better and smarter and changing the way we live, work, play and think about what’s possible.

Nominations are solicited from editors and correspondents around the world and through an online application process, then evaluated on criteria including originality, creativity, effectiveness, ambition and impact. This year’s list features 100 innovations from around the globe. (You can check out the 2020 winners here.)

Since Johnson & Johnson’s founding 135 years ago, the company has been committed to using its reach and size for good, creating healthier communities and putting a healthy mind, body and environment within reach of everyone, everywhere.

In fact, earlier this year, Johnson & Johnson was chosen for inclusion on the first-ever list of TIME100 Most Influential Companies.

Johnson & Johnson is proud to be named to Time‘s Best Inventions list once again.

More from Johnson & Johnson

What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.